Related references
Note: Only part of the references are listed.Antithymocyte globulin exposure in CD34 + T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja et al.
BLOOD ADVANCES (2022)
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation
Masahiro Teramoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2022)
Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
Volker Wiebking et al.
HAEMATOLOGICA (2021)
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
Coco de Koning et al.
BLOOD (2021)
Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies
Ravi M. Shah
BONE MARROW TRANSPLANTATION (2021)
T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies
Katharina Kleinschmidt et al.
FRONTIERS IN PEDIATRICS (2021)
Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia
Annalisa Ruggeri et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)
Antonio Perez-Martinez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
Susanne H. C. Baumeister et al.
FRONTIERS IN IMMUNOLOGY (2020)
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
Ying-Jun Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Early CD4+T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
Ichelle van Roessel et al.
CYTOTHERAPY (2020)
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis
Denis Claude Roy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2019)
Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation
Ying-Jun Chang et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders
Joseph H. Oved et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes
Lucie M. Turcotte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Beneficial role of CD8+T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting
Attilio Bondanza et al.
BONE MARROW TRANSPLANTATION (2019)
PHASE II STUDY OF HAPLOIDENTICAL STEM CELL TRANSPLANTATION USING EX VIVO PHOTODEPLETION OF DONOR LYMPHOCYTE INFUSIONS TO ELIMINATE ANTI-HOST REACTIVITY RESULTS IN LOW RELAPSE RATES AND HIGH SURVIVAL RATES: FINAL 2 YEAR FOLLOW-UP
D. Roy et al.
CYTOTHERAPY (2018)
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion
Brandon M. Triplett et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
Emilia Salzmann-Manrique et al.
FRONTIERS IN IMMUNOLOGY (2018)
Unrelated donor vs HLA-haploidentical alpha/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia
Alice Bertaina et al.
BLOOD (2018)
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
Antonio Russo et al.
BLOOD (2018)
Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation
Andrew L. Gilman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus
Xu-Ying Pei et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
Federico Simonetta et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide
Franco Aversa et al.
BLOOD ADVANCES (2017)
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion
Franco Locatelli et al.
BLOOD (2017)
Predicting CD4 T-Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation
R. L. Hoare et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults
Amandine Le Bourgeois et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted grafts
M. A. Diaz et al.
BONE MARROW TRANSPLANTATION (2016)
Outcomes of pediatric identical living-donor liver and hematopoietic stem cell transplantation
Steffen Hartleif et al.
PEDIATRIC TRANSPLANTATION (2016)
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Shannon R. McCurdy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Alessandra Roberto et al.
BLOOD (2015)
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
Antonella Mancusi et al.
BLOOD (2015)
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes
Irma Airoldi et al.
BLOOD (2015)
Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies
B. M. Triplett et al.
BONE MARROW TRANSPLANTATION (2015)
Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients
P. Lang et al.
BONE MARROW TRANSPLANTATION (2015)
Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China
Li Gao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY
A. Roberto et al.
BONE MARROW TRANSPLANTATION (2015)
Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2015)
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naive T Cells and Retain Functional Pathogen-Specific Memory T Cells
Marie Bleakley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
Lena Oevermann et al.
BLOOD (2014)
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina et al.
BLOOD (2014)
Transplantation Outcomes for Severe Combined Immunodeficiency, 2000-2009
Sung-Yun Pai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
Aude G. Chapuis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Comparison of Outcomes after HLA-Matched Sibling and Unrelated Donor Transplantation for Children with High-Risk Acute Lymphoblastic Leukemia
Mei-Jie Zhang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia
A. Perez-Martinez et al.
BONE MARROW TRANSPLANTATION (2012)
Negative depletion of CD3+ and TcRαβ+ T cells
Rupert Handgretinger
CURRENT OPINION IN HEMATOLOGY (2012)
HLA Haploidentical Stem Cell Transplantation After Removal of αβ+ T Lymphocytes and B Lymphocytes Is an Effective Treatment for Children with Life-Threatening, Non-Malignant Disorders
Alice Bertaina et al.
BLOOD (2012)
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia
Martin Bornhaeuser et al.
BLOOD (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Thomas Klingebiel et al.
BLOOD (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
Graft Manipulation and Reduced-intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Unrelated and Mismatched/Haploidentical Related Donors in Pediatric Leukemia Patients
Marta Gonzalez-Vicent et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications
Colleen Delaney et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
Jeffrey K. Davies et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation
S. Chaleff et al.
CYTOTHERAPY (2007)
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplant
PJ Amrolia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients:: Preliminary results of a pilot study
P Lang et al.
KLINISCHE PADIATRIE (2005)
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial
JE Wagner et al.
LANCET (2005)
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study
P Lewalle et al.
BONE MARROW TRANSPLANTATION (2003)
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation:: a phase 1/2 study
I André-Schmutz et al.
LANCET (2002)
Tolerance induction by megadose hematopoietic progenitor cells:: expansion of veto cells by short-term culture of purified human CD34+ cells
H Gur et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
VT Ho et al.
BLOOD (2001)
Share Paper
